Interleukin 16 expression in relation to disease activity in rheumatoid arthritis

Journal of Rheumatology

Volumn 28, Issue 1, 2001, Pages 12-21

  Blaschke, S ^a   Schulz, H ^a   Schwarz, G ^a   Blaschke, V ^a   Muller G A ^a   Reuss Borst, M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Disease activity; Interleukin 16; Real time quantitative polymerase chain reaction; Rheumatoid arthritis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 16;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION; INTERLEUKIN-16; MALE; MIDDLE AGED; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0035166936     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rheumatoid arthritis. Pathophysiology and implications for therapy
2. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow-up study
3. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis
4. How important are T cells in chronic rheumatoid synovitis?
5. Altered T lymphocyte signaling in rheumatoid arthritis
6. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis
7. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibodies, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate
8. Role of cytokines in rheumatoid arthritis
9. Expression of interferon-gamma, IL-10, IL-12 and transforming growth factor beta mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis
10. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium
11. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor
12. Molecular and functional analysis of a lymphocyte chemoattractant factor: Association of biologic function with CD4 expression
13. Interleukin-16 and its function as CD4 ligand
14. Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmatic signaling in lymphocytes
15. Synergistic activation of CD4+ T cells by IL-16 and IL-2
16. lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration
17. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction
18. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation
19. Inhibitory effect of interleukin- 16 on interleukin-2 production by CD4+ T cells
20. Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis
21. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis
22. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
23. Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score
24. Tissue and T cell distribution of precursor and mature IL-16
25. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis
26. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue
27. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides
28. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis
29. Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis
30. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis
31. Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation: Evidence for constitutive protein synthesis and storage
32. Processing activation of pro-interleukin- 16 by caspase-3
33. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent
34. Correlation of histochemical, histologic and biochemical evaluations of human synovium with clinical activity
35. The immunohistologic features of synovitis, disease activity and in vitro IgM rheumatoid factor synthesis by blood mononuclear cells in rheumatoid arthritis
36. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis
37. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
38. Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells